During the past decade, Gyeongsang National University Changwon Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gyeongsang National University Changwon Hospital" #1 sponsor was "National Cancer Center, Korea" with 3 trials, followed by "Chonnam National University Hospital" with 2 trials sponsored, "Gyeongsang National University Hospital" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Hallym University Medical Center" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gyeongsang National University Changwon Hospital" #1 collaborator was "Health Insurance Review & Assessment Service" with 1 trials as a collaborator, "Korea Health Industry Development Institute" with 1 trials as a collaborator, "Korean Cancer Study Group" with 1 trials as a collaborator, "Korean Society of Interventional Cardiology" with 1 trials as a collaborator and "U&I Corporation" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Gyeongsang National University Changwon Hospital" are "Coronary Artery Disease" (3 trials), "Gastric Cancer" (2 trials), "Acute Ischemic Stroke" (1 trials), "Advanced Heart Failure" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Gyeongsang National University Changwon Hospital" in a lesser frequency.

Most popular intervention types in "Gyeongsang National University Changwon Hospital" are "Drug" (5 trials), "Procedure" (3 trials), "Device" (2 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Clopidogrel Tablets" (1 trials), "Computed tomography, Chest X-ray, and blood test" (1 trials), "D2 and #14v lymphadenectomy" (1 trials), "D2 lymphadenectomy" (1 trials) and "Dexamethasone implant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gyeongsang National University Changwon Hospital" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Gyeongsang National University Changwon Hospital". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Gyeongsang National University Changwon Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gyeongsang National University Changwon Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".